¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"poliomyelitis immunoglobulin"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® immunoglobulin ÇÑ±Û ¸é¿ª±Û·ÎºÒ¸°
¼³¸í   
  Ç÷û¼ººÐ Áß ¸é¿ª¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí, ¶Ç Ç×ü ÀÛ¿ëÀ» Çϴ ´Ü¹éÁúÀÇ ÃÑĪ. Ç×ü ÀÛ¿ëÀ̶õ Ç׿ø¿¡ ¼±ÅÃÀûÀ¸·Î ¹ÝÀÀÇϴ ±â´ÉÀε¥, ÀÌ ÀÛ¿ëÀ» Çϴ °ÍÀº ´ëºÎºÐ Àü±âÀ̵¿¹ýÀ¸·Î ³ª´­ °æ¿ì °¨¸¶ ¿µ¿ª¿¡ ¼ÓÇϹǷΠ°¨¸¶±Û·ÎºÒ¸°À̶ó°íµµ ÇÑ´Ù. ±âº»±¸Á¶´Â ºÐÀÚ·® ¾à 2¸¸ 3,000ÀÇ L»ç½½(°¡º­¿î »ç½½) ÇÑ ½Ö°ú 5¸¸~7¸¸ÀÇ H»ç½½(¹«°Å¿î »ç½½) ÇÑ ½ÖÀÌ S-S ´Ù¸®°Éħ¿¡ ÀÇÇØ °áÇյȠ°ÍÀÌ´Ù.
  
  ¸é¿ª±Û·ÎºÒ¸°
¿µ¹® poliomyelitis ÇÑ±Û È¸»öÁúô¼ö¿°
¼³¸í   
  »ê¹ßÀû ¶Ç´Â À¯Ç༺À¸·Î ¹ß»ýÇϴ ±Þ¼º¹ÙÀÌ·¯½ºº´À¸·Î¼­, Æú¸®¿À¹ÙÀÌ·¯½º°¡ ¿øÀαÕÀ̸ç À̰ÍÀ̠ô¼öÀÇ ¾Õ»Ô¼¼Æ÷¸¦ ¼±ÅÃÀûÀ¸·Î Ä§¹üÇÏ¿© ¿îµ¿¸¶ºñ¸¦ ÀÏÀ¸Å°´Â °ÍÀ̠Ư¡ÀÌ´Ù. Áï, À̿ϸ¶ºñ¸¦ ³ªÅ¸³»´Â °ÍÀ̳ª °æ·Ã¼º ¹× °õÁö¶ô ¸¶ºñ¸¦ ³ªÅ¸³»´Â ³ú¼º¼Ò¾Æ¸¶ºñ µîÀ» ÃÑĪÇϴ ǥÇöÀÌ´Ù. Ã´¼ö¿°ÀÌÁö¸¸ Ã´¼ö»Ó¸¸ ¾Æ´Ï¶ó ´ë³ú, ¼Ò³ú µî¿¡µµ ¿°ÁõÀ» ÀÏÀ¸Å²´Ù. ÀÌ ¹ÙÀÌ·¯½º´Â Ã¢ÀÚ¹ÙÀÌ·¯½º·Î °¨¿°½Ã À§Ã¢ÀÚ°ü¿°ÀÌ ¹ß»ýÇϴµ¥ ¼Ò¼öÀǠȯÀÚ¿¡¼­ Ç÷ÇàÀ¸·Î ¹ÙÀÌ·¯½º°¡ ÁßÃ߽Űæ°è¸¦ Ä§¹üÇϰԠµÈ´Ù. ÀÏ´Ü ±Þ¼º½Ã¿¡¼­ È¸º¹µÇ´õ¶óµµ ¾Õ»Ô¿îµ¿½Å°æ¼¼Æ÷µéÀÇ ¸¹Àº ¼ö°¡ µ¿½Ã¿¡ ÆÄ±«µÇ±â ¶§¹®¿¡ À̵éÀÌ Áö¹èÇϰí Àִ ±ÙÀ°ÀÇ ¸¶ºñ¸¦ ÃÊ·¡ÇϰԠµÈ´Ù. ¼Ò¾Æ¿¡ ÀÌȯÀ²ÀÌ ³ô°í ¸¶ºñ¸¦ ÀÏÀ¸Å°¹Ç·Î Ã´¼ö¼º ¼Ò¾Æ¸¶ºñ¶ó°íµµ ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • poliomyelitis
    ȸ»öÁúô¼ö¿°
  • cold-insoluble immunoglobulin
    ÇÑ·©ºÒ¿ë¸é¿ª±Û·ÎºÒ¸°
  • immunoglobulin
    ¸é¿ª±Û·ÎºÒ¸°
  • immunoglobulin A
    ¸é¿ª±Û·ÎºÒ¸°A
  • immunoglobulin adhesion receptor
    ¸é¿ª±Û·ÎºÒ¸°ºÎÂø¼ö¿ëü
  • immunoglobulin class
    ¸é¿ª±Û·ÎºÒ¸°°è
  • immunoglobulin cleavage
    ¸é¿ª±Û·ÎºÒ¸°ºÐÇÒ
  • immunoglobulin D
    ¸é¿ª±Û·ÎºÒ¸°D
  • immunoglobulin domain
    ¸é¿ª±Û·ÎºÒ¸°¿µ¿ª
  • immunoglobulin E
    ¸é¿ª±Û·ÎºÒ¸°E
  • immunoglobulin G
    ¸é¿ª±Û·ÎºÒ¸°G
  • immunoglobulin M
    ¸é¿ª±Û·ÎºÒ¸°M
  • immunoglobulin subclass
    ¸é¿ª±Û·ÎºÒ¸°¼­ºêŬ·¡½º
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • poliomyelitis
    ȸ»öÁúô¼ö¿°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • poliomyelitis
    ȸ»öÁúô¼ö¿°
  • cold-insoluble immunoglobulin
    ÇÑ·©ºÒ¿ë¸é¿ª±Û·ÎºÒ¸°
  • immunoglobulin class
    ¸é¿ª±Û·ÎºÒ¸°°è
  • immunoglobulin cleavage
    ¸é¿ª±Û·ÎºÒ¸°ºÐÇÒ
  • immunoglobulin domain
    ¸é¿ª±Û·ÎºÒ¸°¿µ¿ª
  • monoclonal immunoglobulin detection
    ´ÜÀÏŬ·Ð¸é¿ª±Û·ÎºÒ¸°°ËÃâ
  • immunoglobulin
    ¸é¿ª±Û·ÎºÒ¸°
  • immunoglobulin structure
    ¸é¿ª±Û·ÎºÒ¸°±¸Á¶
  • immunoglobulin subclass
    ¸é¿ª±Û·ÎºÒ¸°¼­ºêŬ·¡½º
  • immunoglobulin adhesion receptor
    ¸é¿ª±Û·ÎºÒ¸°ºÎÂø¼ö¿ëü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acute anterior poliomyelitis
    ±Þ¼ºÀü°¢¼ºÈ¸¹é¼ö¿°, Æú¸®¿À
  • acute anterior poliomyelitis =infantile par aly sis
    ±Þ¼º ȸ¹éô¼ö¿°(ÐáàõüéÛÜô±âÐæú).
  • acute poliomyelitis
    ±Þ¼º ȸ¹éô¼ö¿°(¡­üéÛÜô±âÐæú), ±Þ¼º ¼Ò¾Æ¸¶ºñ.
  • acute poliomyelitis
    ±Þ¼ºÈ¸¹é¼ö¿°(~üéÛÜâÐæú),Æú¸®¿À
  • anterior poliomyelitis
    Àü°¢È¸¹é(ô)¼ö¿°(îñÊÇüéÛÜô±âÐæú).
  • poliomyelitis
    ¼Ò¾Æ¸¶ºñ
  • poliomyelitis
    ¼Ò¾Æ¸¶ºñ(á³ä®Ø¦Ýö), ȸ¹é¼ö¿°(üéÛÜâÐæú), Æú¸®¿À
  • poliomyelitis =polio
    ¼Ò¾Æ¸¶ºñ, Æú¸®¿À, ȸ»öô¼ö¿°.
  • HBV immunoglobulin (HBIG)
    BÇü °£¿°¹ÙÀÌ·¯½º ¸é¿ª±Û·ÎºÒ¸°
  • Ig A = immunoglobulin A
    ¸é¿ª¸¦·ÎºóA
  • Ig E = immunoglobulin E
    ¸é¿ª±Û·ÎºóE
  • Ig G = immunoglobulin G
    ¸é¿ª±Û·ÎºóG
  • Ig M = immunoglobulin M
    ¸é¿ª±Û·ÎºóM
  • Immunoglobulin G = Ig G
    ¸é¿ª±Û·ÎºÒ¸°G
  • Immunoglobulin M = Ig M
    ¸é¿ª±Û·ÎºÒ¸°M
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acute anterior poliomyelitis
    ±Þ¼ºÀü°¢¼ºÈ¸¹é¼ö¿°, Æú¸®¿À
  • acute anterior poliomyelitis =infantile par aly sis
    ±Þ¼º ȸ¹éô¼ö¿°(ÐáàõüéÛÜô±âÐæú).
  • acute poliomyelitis
    ±Þ¼ºÈ¸¹é¼ö¿°(~üéÛÜâÐæú),Æú¸®¿À
  • acute poliomyelitis
    ±Þ¼º ȸ¹éô¼ö¿°(¡­üéÛÜô±âÐæú), ±Þ¼º ¼Ò¾Æ¸¶ºñ.
  • anterior poliomyelitis
    Àü°¢È¸¹é(ô)¼ö¿°(îñÊÇüéÛÜô±âÐæú).
  • ascending poliomyelitis
    »óÇ༺ ȸ¹é (ô)¼ö¿°.
  • bulbar poliomyelitis
    ¿¬¼ö¼º ȸ¹é(ô)¼ö¿°(¡­üéÛÜô±âÐæú).
  • encephalitic poliomyelitis
    ³ú¿°Çü ȸ¹é¼ö¿° (~üéÛÜâÐæú), ³ú¿°Çü Æú¸®¿À
  • encephalitic poliomyelitis
    ³ú¿°Çüȸ¹é¼ö¿°, ³ú¿°ÇüÆú¸®¿À
  • epidemic poliomyelitis
    À¯Ç༺ ¼Ò¾Æ¸¶ºñ, À¯Ç༺ ȸ¹éô¼ö¿°.
  • mouse poliomyelitis
    ¸¶¿ì½ºÈ¸¹éô¼ö¿°.
  • nonparalytic poliomyelitis
    ºñ¸¶ºñ¼º ȸ¹éô¼ö¿°.
  • poliomyelitis
    ¼Ò¾Æ¸¶ºñ
  • poliomyelitis
    ¼Ò¾Æ¸¶ºñ(á³ä®Ø¦Ýö), ȸ¹é¼ö¿°(üéÛÜâÐæú), Æú¸®¿À
  • poliomyelitis =polio
    ¼Ò¾Æ¸¶ºñ, Æú¸®¿À, ȸ»öô¼ö¿°.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anti-immunoglobulin antibody
    Ç׸鿪(ù÷Øóæ¹)±Û·ÎºÒ¸° Ç×ü(ù÷ô÷)
  • immunoglobulin
    ¸é¿ª(Øóæ¹)±Û·ÎºÒ¸°
  • immunoglobulin chain
    ¸é¿ª(Øóæ¹)±Û·ÎºÒ¸° »ç½½
  • immunoglobulin fold
    ¸é¿ª(Øóæ¹)±Û·ÎºÒ¸° Á¢±â
  • immunoglobulin gene
    ¸é¿ª(Øóæ¹)±Û·ÎºÒ¸° À¯ÀüÀÚ(ë¶îîí­)
  • 7S immunoglobulin
    7S ¸é¿ª(Øóæ¹)±Û·ÎºÒ¸°
  • 19S immunoglobulin
    19S ¸é¿ª(Øóæ¹)±Û·ÎºÒ¸°
  • type I immunoglobulin
    IÇü(úþ) ¸é¿ª(Øóæ¹)±Û·ÎºÒ¸°
  • type II immunoglobulin
    IIÇü(úþ) ¸é¿ª(Øóæ¹)±Û·ÎºÒ¸°
  • type K immunoglobulin
    KÇü(úþ) ¸é¿ª(Øóæ¹) ±Û·ÎºÒ¸°
  • type L immunoglobulin
    LÇü(úþ) ¸é¿ª(Øóæ¹)±Û·ÎºÒ¸°
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • poliomyelitis
    ¼Ò¾Æ¸¶ºñ, Æú¸®¿À, ȸ»öô¼ö¿°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MIg malaria immunoglobulin; measles immunoglobulin; membrane immunoglobulin
DPTPM diphtheria-pertussis-tetanus-poliomyelitis-measles [vaccine]
IPC intermittent pneumatic compression; International Poliomyelitis Congress; ion pair chromatography; i...
IPV inactivated poliomyelitis vaccine or virus; infectious pustular vaginitis; infectious pustular vulvo...
NP polio nonparalytic poliomyelitis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
OPV Oral Poliomyelitis Vaccine
PPS Post-poliomyelitis syndrome
VAPP Vaccine Associated Paralytic Poliomyelitis
Ig Anti-immunoglobulin
anti-Ig Anti-immunoglobulin
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute poliomyelitis
    ±Þ¼º ȸ¹éô¼ö¿°, ±Þ¼º ¼Ò¾Æ¸¶ºñ
    »ê¹ßÀûÀ¸·Î ¹ß»ýÇÏ´Â ±Þ¼º ¹ÙÀÌ·¯½º ÁúȯÀ¸·Î ¹ß¿­, ÀεΠ¹ßÀû, µÎÅë, ±¸Åä µîÀ» Ư¡À¸·Î ÇÏ°í ¸ñ´ú¹Ì¿Í µî ÂÊ ºÎºÐÀÇ °­Á÷À» µ¿¹ÝÇÑ´Ù.
  • poliomyelitis
    ¼Ò¾Æ¸¶ºñ, Æú¸®¿À, ȸ»öô¼ö¿°, ȸ¹é¼ö¿°
    µ¿ÀǾî=
  • amylase complex with immunoglobulin
    ¸é¿ª ±Û·ÎºÒ¸° ¾Æ¹Ð¶óÁ¦ º¹ÇÕü
  • half-life of immunoglobulin
    ¸é¿ª ±Û·ÎºÒ¸°ÀÇ ¹Ý°¨±â
  • immunoglobulin
    ¸é¿ª ±Û·ÎºÒ¸°
    µ¿ÀǾî=secretory IgA. 1. Ç×ü ±â´ÉÀ» °¡Áö°í ÀÖ°í ±¸Á¶ÀûÀ¸·Î ºñ½ÁÇÑ ´ç ´Ü¹éÀÇ ÃÑĪÀ̸ç, ±¸Á¶ ¹× »ý¹°ÇÐÀû Ȱ¼º¿¡ µû¶ó 5Á¾À¸·Î ±¸ºÐÇÑ´Ù. ¸é¿ª ±Û·ÎºÒ¸° ºÐÀÚÀÇ ±âº»ÀûÀÎ ±¸Á¶ ´ÜÀ§
  • immunoglobulin class
    ¸é¿ª ±Û·ÎºÒ¸° Ŭ¶ó½º
    Ç×ü ±â´ÉÀ» °¡Áö°í ÀÖ°í ±¸Á¶ÀûÀ¸·Î ºñ½ÁÇÑ ´ç ´Ü¹éÀÇ ±¸Á¶ ¹× »ý¹°ÇÐÀû Ȱ¼º¿¡ µû¸¥ 5Á¾ÀÇ Å¬¶ó½º. Áï IgM, IgG, IgA, IgD, IgE.
  • immunoglobulin subclass
    ¸é¿ª ±Û·ÎºÒ¸° ¼­ºêŬ¶ó½º
  • monoclonal immunoglobulin detection
    ´ÜÀÏ Å¬·Ð ¸é¿ª ±Û·ÎºÒ¸° °ËÃâ
  • normal immunoglobulin
    Á¤»ó ¸é¿ª
  • selective deficiencies of immunoglobulin
    ¼±ÅÃÀû ¸é¿ª ±Û·ÎºÒ¸° °áÇÌÁõ
    ´Ù¸¥ ¸é¿ª ±Û·ÎºÒ¸°Àº Á¤»óÀ̰ųª Áõ°¡µÇ¸é¼­ Çϳª ¶Ç´Â µÎ Á¾·ùÀÇ ¸é¿ª ±Û·ÎºÒ¸°ÀÌ °áÇ̵Ǿî ÀÖ´Â °æ¿ì·Î ´ëÇ¥ÀûÀÎ ÁúȯÀ¸·Î´Â IgA °áÇÌÁõ, IgM °áÇÌÁõ, IgG ¾Æ±º °áÇÌÁõ µîÀÌ ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
poliomyelitis immunoglobulin poliomyelitis immune globulin (human)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
acute anterior poliomyelitis Inflammation of the anterior cornua of the spinal cord; an acute infectious disease caused by the poliomyelitis virus and marked by fever, pains, and gastroenteric disturbances, followed by a flaccid paralysis of one or more muscular groups, and later by atrophy.
Synonym: acute atrophic paralysis, myogenic paralysis.
(05 Mar 2000)
acute bulbar poliomyelitis Poliomyelitis virus infection affecting nerve cells in the medulla oblongata and producing paralysis of the lower motor cranial nerves.
(05 Mar 2000)
chronic anterior poliomyelitis Muscular atrophy of the upper extremities and neck, in which there are long intermissions of quiescence or improvement; not to be confused with poliomyelitis virus infections.
(05 Mar 2000)
mouse poliomyelitis Encephalomyelitis due to the mouse encephalomyelitis virus (a species of Enterovirus) which is not pathogenic in monkeys or in man, but attacks mouse colonies and causes a flaccid paralysis, usually of the hind limbs.
Synonym: mouse poliomyelitis, Theiler's disease.
(05 Mar 2000)
mouse poliomyelitis virus A virus of the genus Enterovirus, family Picornaviridae, normally associated with inapparent infections and found in the intestinal tracts of infected mice, occasionally causing mouse encephalomyelitis in experimentally inoculated susceptible mice.
Synonym: mouse poliomyelitis virus.
(05 Mar 2000)
poliomyelitis <disease, virology> An acute viral disease, occurring sporadically and in epidemics and characterised clinically by fever, sore throat, headache and vomiting, often with stiffness of the neck and back. In the minor illness these may be the only symptoms.
The major illness, which may or may not be preceded by the minor illness, is characterised by involvement of the central nervous system, stiff neck, pleocytosis in the spinal fluid and perhaps paralysis. There may be subsequent atrophy of groups of muscles, ending in contraction and permanent deformity.
The major illness is called acute anterior poliomyelitis, infantile paralysis and Heine Medin disease. The disease is now largely controlled by vaccines.
Origin: Gr. Myelos = marrow
(18 Nov 1997)
poliomyelitis, bulbar A serious form of poliomyelitis in which the medulla oblongata is affected, and in which there may be dysfunction of the swallowing mechanism, and respiratory and circulatory distress.
(12 Dec 1998)
poliomyelitis immune globulin A sterile solution of globulin's that contains those antibodies normally present in adult human blood; it is a passive immunologic agent that attenuates or prevents poliomyelitis, measles, and infectious hepatitis, and confers temporary but significant protection against paralytic polio.
Synonym: poliomyelitis immunoglobulin.
(05 Mar 2000)
poliomyelitis vaccines Inactivated poliovirus vaccine (IPV), an aqueous suspension of inactivated strains of poliomyelitis virus (types 1, 2, and 3) used by injection; has largely been replaced by the oral vaccine.
See: Salk vaccine.
(05 Mar 2000)
poliomyelitis virus The picornavirus (genus Enterovirus) causing poliomyelitis in humans; the route of infection is the alimentary tract, but the virus may enter the bloodstream and nervous system, sometimes causing paralysis of the limbs and, rarely, encephalitis; many infections are inapparent; serologic types 1, 2, and 3 are recognised, type 1 being responsible for most paralytic poliomyelitis and most epidemics.
Synonym: poliovirus hominis, poliovirus.
(05 Mar 2000)
anti-D immunoglobulin rHo(D) immune globulin
rabies immunoglobulin rabies immune globulin (human)
genes, immunoglobulin Genes encoding the light and heavy chain segments of immunoglobulins. Light chain gene segments are symbolised l-v (variable), j (joining) and c (constant); ig heavy chain segments have, in addition, a diversity (d) gene. Each segment codes for certain amino acids, and each has a different nucleotide sequence; the genes are assembled by a remarkable shuffling of the segments during b lymphocyte maturation.
(12 Dec 1998)
receptors, polymeric immunoglobulin Specialised fc receptors (receptors, fc) for polymeric immunoglobulins, which mediate transcytosis of polymeric IgA and IgM into external secretions. They are found on the surfaces of epithelial cells and hepatocytes. After binding to IgA, the receptor-ligand complex undergoes endocytosis, transport by vesicle, and secretion into the lumen by exocytosis. Before release, the part of the receptor (secretory component) that is bound to IgA is proteolytically cleaved from its transmembrane tail.
(12 Dec 1998)
measles immunoglobulin measles immune globulin (human)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immunoglobulin
    ¸é¿ª ±Û·ÎºÒ¸°
  • poliomyelitis
    ¼Ò¾Æ¸¶ºñ
  • poliomyelitis
    ô¼ö ȸ¹éÁú¿°;¼Ò¾Æ¸¶ºñ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á